MeiraGTx Holdings plc

NASDAQ:MGTX

Biotechnology

Healthcare
$8.32 +5.08%

+$0.53 today

Market cap
$813.12M
Beta
1.26
P/E (TTM)
-7.4
EPS (TTM)
-$1.48
52W Low $6.07High $11.85

Volume 0.58M

Average 0.84M

MGTX Operating Income

Profit from core operations after operating expenses, before interest and taxes.

MeiraGTx Holdings plcNASDAQ: MGTX

Operating Income · Q1 FY2026 · quarter ended Mar 2026

Operating income remains negative

Q1 FY2026 operating income was -$40.82M, compared with -$41.6M a year earlier. Trailing-twelve-month operating income was -$105.19M.

Context

  • Operating income amounted to 130.2% of revenue in FY2025, down 363.2 pp from a year earlier.
  • Operating income grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether operating income reaches the consensus estimate from 5 analysts of $41.3M (+139.0%) for the fiscal year ending Dec 2026, a step up from the +35.5% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$40.82M-254.2% QoQ
Last fiscal yearDec 2025
-$105.97M+35.5% YoY
LTMMar 2026
-$105.19M+33.9% YoY
Operating Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.9%+8.7%+6.8 pp
1 year+35.5%+139.0%+103.5 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Income history

USD · from the income statement

Latest · FY2025
(105.97M) USD
Year-over-year change
+35.5%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Income vs competitors

How MGTX compares with its peers on the latest reported figures

  • MGTX's LTM Mar 2026 operating income of -$105.19M is the 4th highest of the 9 companies compared; the peer median is -$185.44M.
  • Its year-over-year change of +33.9% is the 2nd highest of 9, against a peer median of -12.3%.
  • Operating income amounts to 131.9% of revenue for MGTX, versus a peer median of 292.3%.
MGTX Competitors Peer median
Operating Income for MGTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
KRYSKrystal Biotech, Inc.LTM Jun 2026$197.92M +42.1%—44.9%
LCTXLineage Cell Therapeutics, Inc.LTM Mar 2026-$37.71M -76.8%—255.1%
OCGNOcugen, Inc.LTM Mar 2026-$66.25M -16.1%—1483.9%
MGTXMeiraGTx Holdings plcLTM Mar 2026-$105.19M +33.9%—131.9%
FDMT4D Molecular Therapeutics, Inc.LTM Mar 2026-$179.55M +11.7%—203.5%
QUREuniQure N.V.LTM Mar 2026-$191.33M -12.9%—1057.5%
SANASana Biotechnology, Inc.LTM Mar 2026-$237.56M -11.7%——
RGNXREGENXBIO Inc.LTM Mar 2026-$256.69M -63.1%—292.3%
NTLAIntellia Therapeutics, Inc.LTM Mar 2026-$420.72M +22.2%—636.6%
Peer median (excluding MGTX) -$185.44M-12.3%—292.3%

Competitors are the stored peer set for MGTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue37.7M15.92M14.02M33.28M81.39M
Cost of Revenue00023.79M4.84M
Gross Profit37.7M15.92M14.02M9.49M76.55M
Gross Margin100.0%100.0%100.0%28.5%94.0%
Research & Development66.69M85.73M103.79M119.48M129.62M
Selling, General & Admin43.77M46.55M47.29M54.22M52.9M
Operating Expenses110.46M132.28M151.08M173.7M182.52M
Depreciation & Amortization7.87M8.6M13.73M12.83M12.61M
EBITDA(71.4M)(116.07M)(57.05M)(121.69M)(89.4M)
EBITDA Margin-189.4%-729.1%-407.0%-365.7%-109.8%
Operating Income(72.76M)(116.36M)(137.06M)(164.21M)(105.97M)
Operating Margin-193.0%-730.9%-977.8%-493.4%-130.2%
Interest Income212K777K2.27M4.15M1.82M
Interest Expense288K4.95M13.25M13.27M12.2M
Other Income / Expenses(6.8M)(13.26M)53.03M16.42M(8.23M)
Income Before Tax(79.56M)(129.62M)(84.03M)(147.79M)(114.2M)
Pre-Tax Margin-211.0%-814.2%-599.5%-444.1%-140.3%
Income Tax Expense00000
Net Income(79.56M)(129.62M)(84.03M)(147.79M)(114.2M)
Net Margin-211.0%-814.2%-599.5%-444.1%-140.3%
EPS (Basic)(1.80)(2.87)(1.49)(2.12)(1.42)
EPS (Diluted)(1.80)(2.87)(1.49)(2.12)(1.42)
Weighted Avg Shares44.14M45.18M56.49M69.82M80.43M
Weighted Avg Shares (Diluted)44.14M45.18M56.49M69.82M80.43M

MeiraGTx Holdings plc

NASDAQ:MGTX

Intrinsic Alpha fair value

Locked

Current Price

$8.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.